Enhanced OXER1 expression is indispensable for human cancer cell migration.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
20 12 2021
Historique:
received: 27 09 2021
accepted: 05 11 2021
pubmed: 15 11 2021
medline: 4 1 2022
entrez: 14 11 2021
Statut: ppublish

Résumé

OXER1 is a recently identified receptor, binding the arachidonic acid metabolic product 5-oxo-ETE, considered an inflammatory receptor, implicated in chemoattraction of circulating mononuclear cells, Ca

Identifiants

pubmed: 34775286
pii: S0006-291X(21)01527-8
doi: 10.1016/j.bbrc.2021.11.024
pii:
doi:

Substances chimiques

5-oxo-eicosatetraenoic acid 0
Arachidonic Acids 0
OXER1 protein, human 0
Receptors, Eicosanoid 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

95-100

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Marilena Kampa reports financial support was provided by Hellenic Foundation for Research and Innovation.

Auteurs

Konstantina Kalyvianaki (K)

Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, Greece.

Irene Drosou (I)

Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, Greece.

George Notas (G)

Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, Greece.

Elias Castanas (E)

Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, Greece. Electronic address: castanas@uoc.gr.

Marilena Kampa (M)

Laboratory of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, Greece. Electronic address: kampam@uoc.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH